Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia.
Citrome L, Such P, Yildirim M, Madera-McDonough J, Beckham C, Jin N, Watkin S, Zhang Z, Larsen F, Harlin M. Citrome L, et al. Among authors: madera mcdonough j. Ther Adv Psychopharmacol. 2024 Nov 12;14:20451253241286319. doi: 10.1177/20451253241286319. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 39534012 Free PMC article. Review.
Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii®) in people with bipolar I disorder: a Plain Language Summary of Publication.
McIntyre RS, Such P, Yildirim M, Madera-McDonough J, Jin N, Watkin S, Zhang Z, Larsen F, Harlin M. McIntyre RS, et al. Among authors: madera mcdonough j. Ther Adv Psychopharmacol. 2024 Oct 27;14:20451253241278830. doi: 10.1177/20451253241278830. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 39469110 Free PMC article. Review.
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
Citrome L, Such P, Yildirim M, Madera-McDonough J, Beckham C, Zhang Z, Larsen F, Harlin M. Citrome L, et al. Among authors: madera mcdonough j. J Clin Psychiatry. 2023 Sep 4;84(5):23m14873. doi: 10.4088/JCP.23m14873. J Clin Psychiatry. 2023. PMID: 37672016 Free article. Clinical Trial.
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison.
Harlin M, Chepke C, Larsen F, Bell Lynum KS, Chumki SR, Fitzgerald H, Such P, Madera-McDonough J, Yildirim M, Panni M, Saklad SR. Harlin M, et al. Among authors: madera mcdonough j. Neuropsychiatr Dis Treat. 2023 Jun 8;19:1409-1416. doi: 10.2147/NDT.S412357. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 37313228 Free PMC article.
Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study.
McIntyre RS, Such P, Yildirim M, Madera-McDonough J, Zhang Z, Larsen F, Harlin M. McIntyre RS, et al. Among authors: madera mcdonough j. Curr Med Res Opin. 2023 Jul;39(7):1021-1030. doi: 10.1080/03007995.2023.2219155. Epub 2023 Jun 9. Curr Med Res Opin. 2023. PMID: 37272079 Free article. Clinical Trial.
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder.
Harlin M, Yildirim M, Such P, Madera-McDonough J, Jan M, Jin N, Watkin S, Larsen F. Harlin M, et al. Among authors: madera mcdonough j. CNS Drugs. 2023 Apr;37(4):337-350. doi: 10.1007/s40263-023-00996-8. Epub 2023 Mar 24. CNS Drugs. 2023. PMID: 36961650 Free PMC article. Clinical Trial.
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials.
Adler LA, Adams J, Madera-McDonough J, Kohegyi E, Hobart M, Chang D, Angelicola M, McQuade R, Liebowitz M. Adler LA, et al. Among authors: madera mcdonough j. J Clin Psychopharmacol. 2022 Sep-Oct 01;42(5):429-439. doi: 10.1097/JCP.0000000000001575. Epub 2022 Jun 2. J Clin Psychopharmacol. 2022. PMID: 35652746 Free PMC article. Clinical Trial.